Phototherapy Devices Market (2026 - 2036)

Phototherapy Devices Market Size, Market Forecast and Outlook By FACT.MR

The Phototherapy Devices market was valued at USD 0.80 billion in 2025, projected to reach USD 0.86 billion in 2026, and is forecast to expand to USD 1.69 billion by 2036 at a 7.0% CAGR. Rising global prevalence of chronic skin disorders including psoriasis and vitiligo, combined with the expanding clinical evidence base for phototherapy in neonatal jaundice management, drives systematic adoption of light-based therapeutic devices across hospital dermatology units and homecare settings. Clinician preference for non-pharmacological treatment pathways with proven safety profiles accelerates phototherapy device procurement in dermatology departments facing antibiotic stewardship constraints.

The absolute dollar growth of USD 0.83 billion over the forecast decade reflects expanding device installed base deployment across both institutional and home care settings. LED-based device capture of 57.6% of product type share signals the clinical and commercial transition away from conventional fluorescent phototherapy toward energy-efficient, narrow-spectrum LED platforms offering superior treatment precision and lower operational costs. Hospital end-user dominance at 35.0% of market share indicates tertiary dermatology centers as primary volume procurement authorities, while growing home care segment penetration demonstrates successful prescribing pathway development for outpatient phototherapy.

Based on FACT.MR's regional analysis, China leads growth at a 9.45% CAGR as government healthcare infrastructure expansion programs fund dermatology department upgrades across tier-2 and tier-3 hospital networks. India advances at 8.75% as private multispecialty hospital chains invest in phototherapy equipment for rapidly expanding dermatology outpatient volumes. Germany registers 8.05% growth, where statutory health insurance Krankenkassen reimbursement coverage for phototherapy procedures sustains consistent device replacement and upgrade procurement. Brazil tracks at 7.35% as public health network investment in dermatology services expands phototherapy availability beyond major metropolitan centers. The United Kingdom records 6.65%, where NICE clinical guidelines endorsing phototherapy for psoriasis and eczema direct NHS dermatology budget allocation toward LED device upgrades. The United States advances at 5.95%, supported by insurance reimbursement standardization for phototherapy sessions in accredited dermatology practices. Japan registers 5.25% as long-established phototherapy clinical protocols in dermatology centers sustain steady device replacement demand.

Phototherapy Devices Market Key Takeaways

Phototherapy Devices Market Definition

Phototherapy Devices encompass medical equipment utilizing controlled-spectrum light energy to treat dermatological conditions, neonatal jaundice, and mood disorders through targeted photobiological mechanisms. Core device categories include LED-based phototherapy units, conventional fluorescent phototherapy systems, and fiber optic light delivery platforms compliant with applicable medical device regulatory standards. Devices deliver white, red, or blue light wavelengths calibrated for specific clinical applications across hospital, dermatology clinic, and homecare treatment environments.

Phototherapy Devices Market Inclusions

Market scope covers LED-based, conventional fluorescent, and fiber optic phototherapy device categories used across skin disease treatment, neonatal jaundice management, seasonal affective disorder therapy, and sterilization applications. End-user analysis encompasses hospital dermatology departments, homecare settings, and specialist dermatology clinics. Regional and country-level market sizing spans North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa for the 2026 to 2036 forecast period.

Phototherapy Devices Market Exclusions

Cosmetic light-based devices lacking medical device regulatory clearance for therapeutic indications are excluded from market scope. Laser therapy systems operating outside phototherapy wavelength classifications fall outside defined boundaries. Sunbed and tanning equipment marketed exclusively for aesthetic purposes without clinical phototherapy claims are omitted. Diagnostic light-based imaging devices and photodynamic therapy drug-device combination products are explicitly excluded from the valuation.

Phototherapy Devices Market Research Methodology

• Primary Research: Analysts conducted interviews with dermatology department procurement directors, hospital biomedical engineering managers, and national health insurance reimbursement officers to document phototherapy device adoption timelines.
• Desk Research: Data collection aggregated national medical device regulatory databases, health technology assessment reports for phototherapy reimbursement coverage, and dermatology society clinical guideline publications.
• Market-Sizing and Forecasting: Baseline values derive from a bottom-up aggregation of phototherapy device installed base and replacement cycle data, applying disease prevalence growth curves and healthcare infrastructure expansion rates to projection models.
• Data Validation and Update Cycle: Forecasts cross-validate against medical device company annual report segment disclosures and national health technology assessment body phototherapy reimbursement coverage databases.

Summary of Phototherapy Devices Market

• Phototherapy Devices Market Definition
  • The Phototherapy Devices market comprises medical-grade light therapy equipment delivering calibrated white, red, and blue light wavelengths for skin disorder treatment, neonatal jaundice management, and mood disorder therapy across hospital, clinic, and homecare settings.
• Demand Drivers in the Market
  • Rising global psoriasis and vitiligo prevalence across adult populations aged 30 to 60 years drives recurrent dermatology department demand for LED phototherapy device procurement as first-line non-pharmacological treatment.
  • National health insurance reimbursement coverage expansion for phototherapy sessions by Germany's statutory health insurance system and NICE guideline endorsements in the UK anchor institutional device procurement budgets.
  • Home care phototherapy prescribing programs developed by dermatology centers reduce hospital outpatient visit burden while expanding the total installed device base into residential settings across high-income markets.
• Key Segments Analyzed in the FACT.MR Report
  • LED-based Phototherapy Devices leads by Product Type with 57.6% share in 2026, as energy efficiency, narrow-spectrum precision, and lower device maintenance costs drive clinical replacement of conventional fluorescent systems.
  • White Light Phototherapy Devices command 55.6% of Light Type share in 2026, supported by broad clinical application across seasonal affective disorder treatment, neonatal jaundice, and full-spectrum dermatology indications.
  • Skin Disease Treatment captures 33.0% of Application share in 2026, reflecting high psoriasis, vitiligo, and eczema procedure volumes generating consistent device utilization across hospital and clinic settings.
• Analyst Opinion at FACT.MR
  • Shambhu Nath Jha, Principal Consultant, opines: 'The phototherapy device market is bifurcating along a technology replacement axis. Hospitals operating conventional fluorescent units face mounting pressure from LED upgrade pathways that offer measurable energy consumption reductions and improved dose delivery precision. Device vendors unable to demonstrate clinical outcome comparability between LED and conventional platforms through peer-reviewed trial data will lose ground in formulary selection processes at major academic medical centers where evidence-based procurement criteria define purchasing decisions.'
• Strategic Implications / Executive Takeaways
  • Phototherapy device manufacturers must prioritize LED platform certification under EU Medical Device Regulation 2017/745 and FDA 510(k) clearance pathways to qualify for tender participation in European and North American hospital procurement cycles.
  • Home care segment expansion requires device design adaptations including user-friendly interfaces, remote treatment monitoring, and teleconsultation integration to satisfy dermatologist prescribing and patient safety requirements.
  • Market entry into India and China tier-2 hospital segments demands localized pricing strategies and service network deployment to compete with domestic device producers in government-funded dermatology infrastructure programs.
• Methodology
  • Primary Research: FACT.MR conducted interviews with dermatology procurement directors and health insurance reimbursement officers across 40 countries to validate device adoption and coverage timelines.
  • Desk Research: Analysts aggregated medical device regulatory databases, health technology assessment reports, and dermatology society clinical guideline publications.
  • Market-Sizing and Forecasting: Bottom-up methodology starting with phototherapy device installed base and replacement cycle data projects forward adoption curves by product type and end user.
  • Data Validation: Cross-validation against medical device company annual report segment disclosures and health technology assessment phototherapy reimbursement databases.

Demand Analysis of Phototherapy Devices (2021 to 2025) Vs Market Outlook for 2026 to 2036

Phototherapy devices are used for treating neonatal jaundice and various skin conditions. These cost-effective phototherapy devices are extensively used in procedures such as reducing bilirubin serum concentration or curing bilirubin toxicity.

Heliotherapy devices are used in treating hyperbilirubinemia in both hemolytic and non-hemolytic conditions. Light therapy devices can effectively reduce the need for frequent blood transfusions. Phototherapy devices are facilitating greater patient convenience and hence witnessing the widespread adoption of phototherapy machines in hospitals and clinics.

Increasing prevalence of skin ailments such as psoriasis and eczema across the globe and the advancement of phototherapy technology is expected to influence the global market for phototherapy devices over the forecast period.

Growing demand for infant phototherapy devices, rising sales of LED-based phototherapy equipment, and the presence of top manufacturers of phototherapy devices are driving the market growth.

What are the Main Factors Fueling Market Growth for Phototherapy Devices?

As the number of patients with skin conditions continues to soar, the urgency of developing advanced phototherapy treatment modules also grows in parallel.

Introduction of cost-effective phototherapy solutions based on LED technology that is more efficient than conventional devices is bringing hope to patients. Over the years, phototherapy treatment has continuously evolved due to the arrival of new technological peripherals.

Factors as such, have been instrumental in driving the demand for phototherapy machines. Infant phototherapy devices are being increasingly used in treating neonatal jaundice, which is common among newborn babies with high amount of bilirubin levels.

Latest innovations in phototherapy devices, prominent players in the market for phototherapy equipment, and growing demand for technologically advanced phototherapy equipment are expected to fuel the market growth over the next ten years.

What Restraints are Being Faced by Phototherapy Device Manufacturers?

High risk of adverse side-effects and increasing availability of alternative modes of treatments along with strict regulatory norms on new product approvals are some of the major growth deterrents of the light therapy devices market.

Which Region is a Lucrative Market for Phototherapy Device Suppliers?

In terms of revenue, the phototherapy devices market in North America is expected to remain highly attractive throughout the forecast period. In addition, the North American regional market is projected to expand 1.3X by 2031.

The market for phototherapy devices is expected to witness healthy growth in the region due to the presence of a favorable reimbursement structure, rising use of heliotherapy devices in neonatal jaundice cases, and a growing number of persons suffering from skin illnesses.

In addition, anticipated introduction of new products, rising preference for phototherapy equipment for home care, and growing adoption of advanced phototherapy technology are projected to accelerate market growth in North America.

Country-wise Analysis

What is the Phototherapy Devices Demand Outlook for the U.S.?

The U.S dominates the global market for phototherapy devices in terms of revenue. The market is expected to increase 1.5X by 2031.

Rising awareness about the benefits of phototherapy, growing concern for seasonal affective disorders, and a high frequency of skin conditions like vitiligo, psoriasis, and eczema are the major factors promoting the adoption of phototherapy devices in the U.S.

Developed healthcare infrastructure and the presence of manufacturers of phototherapy devices in the U.S. are the major drivers for the market growth in the country.

Why are Sales of Phototherapy Devices Surging in China?

Rising awareness of modern phototherapy, high per-capita disposable income, and the expansion of healthcare infrastructure is boosting the sales of phototherapy devices in China.

Moreover, growth in the percentage of newborns in China, an increase in the prevalence of neonatal jaundice, and the necessity for cost-effective devices are all expected to fuel the market growth in China.

Category-wise Insights

Why are LED-based Phototherapy Devices Gaining Immense Popularity?

LED-based phototherapy devices hold a significant market share. Sales of LED-based phototherapy devices are expected to increase by 2.1X over the forecast period.

LEDs are used as a light source in LED-based phototherapy devices to precisely focus the appropriate wavelength light on the affected area. Furthermore, because of the high amount of radiation, the treatment period associated with LED devices is less than that of conventional devices.

The intensity of LEDs does not decrease over time, and they can be used for at least 3,000 hours. Furthermore, because their spectrum is concentrated in the blue region of visible light, they are less fragile and do not emit high heat.

Rising incidence of newborn jaundice and the expanding acceptance of LED-based phototherapy equipment for target disease management are driving the demand for LED-based phototherapy devices.

Why is Demand for Phototherapy Devices for Skin Disease Treatments High?

Based on application, skin disease treatment is expected to be the largest contributor to the market.

The frequency of skin diseases has increased worldwide, according to the World Health Organization (WHO). The rising prevalence of psoriasis, as well as the expanding need for psoriasis treatment, and latest trends in phototherapy devices are driving the demand for phototherapy to treat skin issues.

Due to increase in skin-related diseases and high recurrence, demand for phototherapy devices to treat skin issues is on the rise, particularly psoriasis, which ranks first, followed by eczema and cancer.

Scope of the Report

Key Segments Covered in Phototherapy Devices Industry Research

• Product Type

  • LED-based Phototherapy Devices
  • Conventional Phototherapy Devices
  • Fiber Optic Phototherapy Devices
  • Others
    • Full-body
    • Partial-body
    • Mobile Infant
    • Fixed Infant
    • Conventional Phototherapy Devices with Compact Fluorescent Lamp
    • Conventional Phototherapy Devices with Fluorescent Lamp

• Light Type

  • White Light Phototherapy Devices
  • Red Light Phototherapy Devices
  • Blue Light Phototherapy Devices
  • Others

• Application

  • Skin Disease Treatment
  • Psoriasis
  • Vitiligo
  • Eczema
  • Neonatal Jaundice Management
  • Scleroderma
  • Seasonal Affective Disorder (SAD)
  • Skin Cancer
  • Sterilization

• End User

  • Hospitals
  • Home Care Settings
  • Dermatology Clinics

Bibliography

• World Health Organization. (2024). Global report on psoriasis. WHO Press.
• European Medicines Agency. (2024). Guideline on clinical investigation of medicinal products for the treatment of psoriatic disease. EMA.
• National Institute for Health and Care Excellence. (2024). Psoriasis: Assessment and management. NICE Guideline NG96. NICE.
• United States Food and Drug Administration. (2024). Guidance for phototherapy devices: 510(k) premarket notification requirements. FDA.
• Organisation for Economic Co-operation and Development. (2024). Health at a glance 2024: OECD indicators. OECD Publishing.
• German Institute for Quality and Efficiency in Health Care (IQWiG). (2024). Phototherapy for psoriasis: Benefit assessment. IQWiG.

This bibliography is provided for reader reference. The full FACT.MR report contains the complete reference list with primary research documentation.

This Report Addresses

• Market sizing and quantitative forecast metrics detailing revenue projections for the Phototherapy Devices market across product type and end-user categories through 2036.
• Segmentation analysis mapping adoption velocity across LED, conventional, and fiber optic device categories by light type and clinical application.
• Regional intelligence comparing reimbursement-driven device procurement in Germany and the UK against infrastructure-led demand growth in China and India.
• Regulatory compliance assessment analyzing EU MDR 2017/745, FDA 510(k), and national health technology assessment requirements governing phototherapy device market access.
• Competitive landscape evaluation tracking LED technology transition strategies among established phototherapy device manufacturers.
• Clinical evidence analysis identifying NICE guideline, AAD recommendation, and statutory health insurance coverage developments shaping institutional procurement decisions.
• Home care segment guidance defining device design, remote monitoring, and prescribing pathway requirements for outpatient phototherapy program expansion.
• Custom data delivery formats encompassing interactive dashboards, raw Excel datasets, and comprehensive PDF narrative reports.